Two compounds are generating increasing interest in the brain-health conversation: plasmalogens and Lion’s Mane mushroom (Hericium erinaceus). Both are positioned as potential supports for the aging brain, yet they operate through entirely different mechanisms and sit at very different points on the evidence spectrum. Knowing those distinctions matters before treating either as a reliable intervention.
Plasmalogens are a class of ether phospholipids embedded in human cell membranes, especially abundant in the brain. Lion’s Mane is a medicinal mushroom whose active compounds—hericenones and erinacines—have been studied for their neurotrophic effects. Neither is a drug, neither carries a proven cure, and both are subjects of ongoing but still early-stage human research. This article covers what the current evidence actually says about each, where it falls short, and how the two approaches compare mechanistically.
Key Takeaways
- Lion’s Mane (Hericium erinaceus) contains hericenones and erinacines that stimulate Nerve Growth Factor production; human trials show cognitive and mood benefits in young adults [2] and measurable acute cognitive effects from single doses [3].
- Plasmalogens are structural brain phospholipids that decline with aging and Alzheimer’s disease; the deficiency-disease link is scientifically established, but direct evidence that oral supplementation produces clinical cognitive benefit in humans remains preliminary.
- These two approaches target different mechanisms—plasmalogens address membrane structure and antioxidant defence, while Lion’s Mane stimulates neurotrophic signalling—making them theoretically complementary rather than interchangeable.
- Both lack large-scale randomised controlled trial data in humans; neither should be treated as a proven treatment for cognitive decline, and both are best understood as research-stage supplements with plausible but unconfirmed clinical benefits.
- Extract quality and standardisation vary significantly for both; consult a qualified healthcare provider before supplementing, particularly if you are managing a cognitive condition or taking prescription medications.
What Are Plasmalogens and Why Do They Matter for the Brain?
Plasmalogens are a subclass of phospholipids defined by a vinyl ether bond at the sn-1 position of the glycerol backbone. They are structural components of cell membranes and are especially concentrated in neurons, accounting for roughly 20% of total phospholipid mass in the human brain. Their highest concentrations are found in regions associated with memory and executive function.
Two main mechanisms are proposed. First, plasmalogens contribute to membrane fluidity and the efficiency of signal transduction—processes that degrade in neurodegenerative conditions. Second, the vinyl ether bond appears to function as a sacrificial antioxidant, scavenging reactive oxygen species before they damage more critical membrane structures. Importantly, plasmalogen levels measurably decline with normal aging and are substantially reduced in individuals with Alzheimer’s disease, which forms the core scientific rationale for supplementation research.
Dietary sources include seafood (particularly scallops and sea urchin), chicken, and beef. Supplements are typically derived from scallop byproducts. The mechanism is biologically plausible and the deficiency-disease association is established, but the direct human evidence that oral supplementation raises brain plasmalogen levels and meaningfully translates to cognitive benefit remains limited in scale and geographic scope. Robust, large randomised controlled trials have not yet been completed.
How Does Lion's Mane Work? The Neurotrophic Mechanism
Hericium erinaceus contains two families of bioactive compounds relevant to cognitive health: hericenones (predominantly in the fruiting body) and erinacines (predominantly in the mycelium). Both groups can cross the blood-brain barrier and have been shown in preclinical work to stimulate synthesis of Nerve Growth Factor (NGF), a neurotrophin that supports the growth, maintenance, and survival of neurons—including cholinergic neurons in the basal forebrain, a population vulnerable in early Alzheimer’s disease.
A narrative review of phytochemical and fungal bioactive compounds described neurostimulating, neurotrophic, and neuroprotective effects that may act in synergy within mushroom-derived compounds [4]. Beyond NGF, Lion’s Mane has been examined for anti-inflammatory activity, antioxidant properties, and potential influence on mood regulation. Research on its antidepressant-relevant mechanisms has noted possible effects on serotonergic and anti-neuroinflammatory pathways [1], suggesting a broader neurobiological footprint than a single-pathway supplement.
Human Trial Evidence for Lion's Mane
The human evidence base for Lion’s Mane, while still modest, includes controlled trials. A double-blind, parallel-groups pilot study in young adults found that Lion’s Mane supplementation produced improvements in cognitive function scores alongside reductions in stress and mood disturbance compared to placebo [2]. The study population was healthy and relatively young, so extrapolating directly to clinical cognitive decline requires caution, but the signal is meaningful for establishing that effects are detectable in humans.
A separate study examining acute effects found that a Nordic Lion’s Mane extract produced measurable improvements on cognitive performance tasks within hours of a single dose [3]. Acute and longer-term effects likely operate through different mechanisms—the former may reflect direct neurochemical activity, while the latter probably involves the slower process of NGF upregulation and structural neuronal remodelling.
Older trials in Japanese adults with mild cognitive impairment have shown improvements on cognitive testing after 12–16 weeks, though these are not in the evidence set for this article and therefore cannot be cited here. Across published studies, the consistent limitation is small sample sizes and significant variation in extract type, dose, and the ratio of fruiting body to mycelium used—making direct comparison between studies difficult.
Plasmalogen Evidence: An Honest Assessment
Plasmalogen research in humans is earlier-stage than Lion’s Mane. The strongest signal comes from observational, epidemiological, and post-mortem data showing that plasmalogen deficiency correlates with Alzheimer’s disease severity, and from animal model studies demonstrating that restoring plasmalogen levels can reduce amyloid burden and improve cognitive performance. Human supplementation trials—primarily from Japanese research groups using scallop-derived plasmalogen—do exist and some report improvements in cognitive testing scores in patients with mild Alzheimer’s, but most involve fewer than 100 participants and short follow-up windows.
No plasmalogen human trial studies are included in the evidence set used for this article, which itself reflects how geographically concentrated and limited in scale this body of research remains. The mechanistic rationale is solid, the deficiency-disease link is well-supported, and early human data is encouraging—but anyone evaluating plasmalogens should be aware that the evidence for clinically meaningful cognitive benefit from oral supplementation is still preliminary.
Mechanistic Differences: Replacement vs. Signalling
Plasmalogens and Lion’s Mane address cognitive vulnerability through largely non-overlapping pathways, which is an important scientific distinction. Plasmalogens operate at the membrane structure level—they are molecules that the brain normally contains in abundance, and supplementing them is conceptually a replenishment strategy: replacing something that aging has depleted. The benefits, if real, would be downstream of restoring normal membrane architecture and antioxidant capacity.
Lion’s Mane is a signalling approach. Its active compounds stimulate the brain’s own production of neurotrophic factors, encouraging the endogenous maintenance machinery to become more active. The neurotrophic and neuroprotective properties documented in mushroom bioactive compound research [4], combined with the mood-relevant and anti-neuroinflammatory effects explored in therapeutic depression research [1], suggest it acts on a broader neurobiological network.
In principle these approaches are complementary rather than competing—one addressing membrane integrity, the other promoting neuronal growth and resilience. Whether combining them produces additive or synergistic benefits in humans has not been tested in any controlled trial.
Practical Considerations: Quality, Safety, and Who Should Be Cautious
Lion’s Mane has a well-established safety profile when consumed as food or as a standardised supplement. Adverse events in published trials are rare and generally mild. However, individuals with mushroom allergies should avoid it. Extract standardisation is variable: products should specify whether they derive from the fruiting body, mycelium, or both, and clearly state the concentration of active compounds such as beta-glucans, hericenones, or erinacines. A product listing only ‘mushroom powder’ provides little assurance of therapeutic dose.
Plasmalogen supplements are typically derived from marine sources, which raises considerations for people with shellfish sensitivities. As a newer supplement category, long-term human safety data is limited. Quality control and bioavailability differ considerably between products and dosage forms. Neither approach should be treated as a substitute for the lifestyle and medical strategies that have the strongest evidence for cognitive health—physical activity, sleep, cardiovascular risk management, and social engagement consistently outperform any single supplement in the broader literature.
🛒 Where to Buy Shilajit
- Pürblack Live ResinLab-tested / studied
resin, ~300-500 mg/day — Premium purified resin, third-party heavy-metal tested; widely regarded as a reference-quality resin. - Toniiq Shilajit
capsules, 500 mg — Standardized fulvic-acid %, third-party tested generic. - Nutricost Shilajit Extract
capsules, 500 mg — Low-cost large-count bottles. - Double Wood Shilajit
capsules, 500 mg — Budget-friendly, COA on request.
As an Amazon Associate we earn from qualifying purchases. Shilajit quality varies widely — always choose a product with a published third-party heavy-metal test (COA) before buying.
A Note on the Evidence
The human evidence base for both plasmalogens and Lion’s Mane is still at an early stage, with most trials involving small samples, short durations, and populations that may not reflect those experiencing significant cognitive decline; nothing in this article should be interpreted as medical advice or as evidence that either supplement treats, prevents, or reverses any cognitive condition. Individuals who are pregnant, breastfeeding, managing a diagnosed neurodegenerative disease, or taking prescription medications should consult a qualified healthcare provider before adding either to their routine.
Frequently Asked Questions
Does Lion's Mane actually improve memory in humans?
Controlled human studies show promising but preliminary results. A double-blind pilot study found cognitive performance improvements alongside reduced stress and mood disturbance in young adults taking Lion’s Mane compared to placebo [2]. Acute effects after a single dose have also been documented on cognitive tasks [3]. The evidence in older adults and those with diagnosed cognitive impairment is limited in scale.
What is a plasmalogen and why does declining levels matter?
Plasmalogens are ether phospholipids that form part of the structural architecture of neuronal cell membranes, functioning as both a structural component and a sacrificial antioxidant protecting cells from oxidative damage. Their levels decline with normal aging and are significantly lower in people with Alzheimer’s disease, which is why researchers are investigating whether supplementing them could slow neurodegeneration—though large human trials confirming this are still absent.
Can Lion's Mane help with mood as well as cognition?
Research suggests Lion’s Mane may have mood-relevant effects alongside its cognitive ones. A review of its therapeutic potential for depressive disorder noted possible antidepressant mechanisms including influence on serotonergic pathways and reduction of neuroinflammation [1]. The pilot cognitive study also observed reduced stress and improved mood scores in participants taking Lion’s Mane versus placebo [2].
How quickly does Lion's Mane take effect?
Effects may appear on two timescales. One study found measurable improvement on cognitive performance tests within hours of a single dose [3], suggesting some acute neurochemical activity. Longer-term benefits likely develop more gradually over weeks as NGF-mediated neuronal support accumulates. The relative contribution of each pathway probably varies with dose, extract type, and individual baseline status.
Is there enough evidence to say one is better than the other for Alzheimer's specifically?
Not on the current evidence. Plasmalogens have a direct mechanistic link to Alzheimer’s pathology through documented deficiency, and some small trials suggest cognitive benefit in mild cases. Lion’s Mane has demonstrated neurotrophic and neuroprotective activity with relevance to neurodegeneration [4], but neither carries an approved treatment indication. Large, independent, well-designed randomised controlled trials are needed for both before any comparative claim can be made responsibly.
Can plasmalogens and Lion's Mane be taken together?
No human trials have specifically studied the combination, so there is no direct safety or efficacy data for co-supplementation. Their mechanisms do not appear to interact adversely in theory, and the pathways they target are largely distinct. Anyone considering combining them—particularly if managing a health condition or taking prescription medications—should consult a qualified healthcare provider first.
References
- Chong PS et al. Therapeutic Potential of Hericium erinaceus for Depressive Disorder. International journal of molecular sciences (2019). PMID 31881712
- Docherty S et al. The Acute and Chronic Effects of Lion's Mane Mushroom Supplementation on Cognitive Function, Stress and Mood in Young Adults: A Double-Blind, Parallel Groups, Pilot Study. Nutrients (2023). PMID 38004235
- La Monica MB et al. Acute Effects of Naturally Occurring Guayusa Tea and Nordic Lion's Mane Extracts on Cognitive Performance. Nutrients (2023). PMID 38140277
- Cipriano GL et al. Phytochemical and Fungal Bioactive Compounds in the "Brain Health Triad": A Narrative Review on Neurostimulating, Neurotrophic, and Neuroprotective Synergy. International journal of molecular sciences (2026). PMID 42074246
As an Amazon Associate we earn from qualifying purchases.